| AAP | American Academy of Pediatrics |
| AI | Adequate Intake |
| apoA | Apolipoprotein A |
| apoB-48 | Apolipoprotein B-48 |
| apoC | Apolipoprotein C |
| apoE | Apolipoprotein E |
| AUC | Area Under the (Concentration–Time) Curve |
| CI | Confidence Interval |
| CM | Chylomicron |
| CR | Chylomicron Remnant |
| CYP4F2 | Cytochrome P450 Family 4 Subfamily F Member 2 |
| ESPGHAN | European Society for Paediatric Gastroenterology, Hepatology and Nutrition |
| GGCX | γ-Glutamyl Carboxylase Gene |
| Gla | γ-Carboxyglutamic Acid |
| HDL | High-Density Lipoprotein |
| HDN | Hemorrhagic Disease of the Newborn |
| HIF-1α | Hypoxia-Inducible Factor 1 Alpha |
| ICH | Intracerebral Hemorrhage |
| IM | Intramuscular |
| IV | Intravenous |
| LDL | Low-Density Lipoprotein |
| LDLR | Low-Density Lipoprotein Receptor |
| LRP1 | LDL Receptor-Related Protein 1 |
| MAPK | Mitogen-Activated Protein Kinase |
| MK-7 | Menaquinone-7 |
| MK-9 | Menaquinone-9 |
| NADPH | Nicotinamide Adenine Dinucleotide Phosphate |
| NASPGHAN | North American Society for Pediatric Gastroenterology, Hepatology and Nutrition |
| NF-κB | Nuclear Factor κ-light-chain-enhancer of activated B cells |
| NICE | National Institute for Health and Care Excellence |
| ODS | Office of Dietary Supplements |
| PCC | Prothrombin Complex Concentrate |
| PDGFRB | Platelet-Derived Growth Factor Receptor Beta |
| PFKFB3 | 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase 3 |
| PIVKA | Proteins Induced by Vitamin K Absence |
| PIVKA-II | Protein Induced by Vitamin K Absence or Antagonist II |
| PPP | Pentose Phosphate Pathway |
| RCT | Randomized Controlled Trial |
| RR | Relative Risk |
| VLDL | Very-Low-Density Lipoprotein |
| VK | Vitamin K |
| VK1 | Vitamin K1 |
| VK2 | Vitamin K2 |
| VKCFD | Vitamin K-Dependent Coagulation Factors Deficiency |
| VKDB | Vitamin K Deficiency Bleeding |
| VKORC1 | Vitamin K Epoxide Reductase Complex Subunit 1 |
| WHO | World Health Organization |